A clinical trial has been approved in Singapore to study the use of traditional Chinese medicine Lianhua Qingwen in treating adults with mild COVID-19.
The study, approved on Jan 18, was initiated by the Singapore Chung Hwa Medical Institution, said the Health Sciences Authority (HSA) in response to CNA's queries on Tuesday (Apr 19).
Singapore's Health Sciences Authority (HSA) has recently given the approval to conduct a clinical trial on the use of Lianhua Qingwen capsules among Covid-19 patients in Singapore.
HQ OFFICE & TOA PAYOH BRANCH:
640 Lorong 4 Toa Payoh Singapore 319522
BLK 679 Woodlands Avenue 6 #01-710 Singapore 730679
Tel: 6366 3246
BUKIT PANJANG BRANCH:
BLK123 Pending Road, #01-42 Singapore 670123
Tel: 6766 7576
BLK 215 Yishun Street 21, #01-301 Singapore 760215
Tel: 6756 7830
JOO CHIAT BRANCH:
291 Joo Chiat Road, JK Centre #02-01 Singapore 427543
Tel: 6444 8727
8 Sinaran Drive, #03-01 VIVA Hub, Novena Specialist Centre, Singapore 307470
Tel: 6334 1290